Literature DB >> 26779576

Light-controlled reactive oxygen species (ROS)-producible polymeric micelles with simultaneous drug-release triggering and endo/lysosomal escape.

Kihong Kim1, Chung-Sung Lee1, Kun Na1.   

Abstract

A doxorubicin (DOX)-loaded and light-induced ROS-producing polymeric micelle (D-LRPM), in which light triggers simultaneous DOX-release and endo/lysosomal escape, produces a powerful, spatiotemporally controllable, therapeutic efficacy for tumor treatment.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26779576     DOI： 10.1039/c5cc09239f

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  7 in total

1.  An enhanced antioxidant strategy of astaxanthin encapsulated in ROS-responsive nanoparticles for combating cisplatin-induced ototoxicity.

Authors:  Jiayi Gu; Xueling Wang; Yuming Chen; Ke Xu; Dehong Yu; Hao Wu
Journal:  J Nanobiotechnology       Date:  2022-06-10       Impact factor: 9.429

2.  Solubilized chlorin e6-layered double hydroxide complex for anticancer photodynamic therapy.

Authors:  Young-Um Jo; HyunJune Sim; Chung-Sung Lee; Kyoung Sub Kim; Kun Na
Journal:  Biomater Res       Date:  2022-06-11

Review 3.  Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting.

Authors:  Xianglei Fu; Yanbin Shi; Tongtong Qi; Shengnan Qiu; Yi Huang; Xiaogang Zhao; Qifeng Sun; Guimei Lin
Journal:  Signal Transduct Target Ther       Date:  2020-11-06

Review 4.  ROS-responsive drug delivery systems.

Authors:  Jing Liang; Bin Liu
Journal:  Bioeng Transl Med       Date:  2016-07-05

Review 5.  Polymeric Carriers for Delivery of RNA Cancer Therapeutics.

Authors:  Sofía Mirón-Barroso; Joana S Correia; Adam E Frampton; Mark P Lythgoe; James Clark; Laura Tookman; Silvia Ottaviani; Leandro Castellano; Alexandra E Porter; Theoni K Georgiou; Jonathan Krell
Journal:  Noncoding RNA       Date:  2022-08-02

Review 6.  Herb Polysaccharide-Based Drug Delivery System: Fabrication, Properties, and Applications for Immunotherapy.

Authors:  Yubiao Cao; Zhuowen Chen; Liangliang Sun; Yameng Lin; Ye Yang; Xiuming Cui; Chengxiao Wang
Journal:  Pharmaceutics       Date:  2022-08-15       Impact factor: 6.525

7.  Hemagglutinin Nanoparticulate Vaccine with Controlled Photochemical Immunomodulation for Pathogenic Influenza-Specific Immunity.

Authors:  Hayoon Jeong; Chung-Sung Lee; Jangsu Lee; Jonghwan Lee; Hee Sook Hwang; Min Lee; Kun Na
Journal:  Adv Sci (Weinh)       Date:  2021-10-24       Impact factor: 16.806
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.